NASDAQ · Medical - Care Facilities

The Joint Corp. (JYNT) Stock

$7.21 -2.24% NASDAQ: JYNT Healthcare

Valuation

MetricValue
Price$7.21
Market Cap$101.90M
P/E Ratio27.44
P/B Ratio6.54
P/S Ratio1.77
EPS (TTM)$0.19
52-Week High$10.67
52-Week Low$6.82
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE22.00%
ROA7.36%
ROCE5.19%
Gross Margin-1.82%
Operating Margin-1.82%
Net Margin6.49%
Debt/Equity0.13
Current Ratio1.58

Annual Financials (USD)

Metric20212022202320242025
Revenue$80.0M$101.0M$47.0M$52.0M$55.0M
Operating Profit$6.0M$1.0M$0$-2.0M$-1.0M
Net Profit$8.0M$1.0M$-10.0M$-6.0M$3.0M
EPS$0.44$0.04$-0.66$-0.39$0.19
Op Margin7.7%0.8%0.7%-3.6%-1.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$87.0M$93.0M$87.0M$83.0M$61.0M
Total Liabilities$57.0M$61.0M$62.0M$62.0M$46.0M
Cash$20.0M$10.0M$18.0M$25.0M$24.0M
Borrowings$24.0M$26.0M$3.0M$1.0M$2.0M

Latest News

The Joint Chiropractic Expands to 44th State with Opening of Rhode Island Clinic PR Newswire · Jul 1, 2026 The Joint Corp. Announces Milind Pant Elected as Director GlobeNewswire · May 21, 2026 Joint Q1 Earnings Call Highlights MarketBeat · May 8, 2026 The Joint Corp. (JYNT) Beats Q1 Earnings and Revenue Estimates Zacks · May 8, 2026 The Joint Corp. Q1 2026 Earnings Call Summary Moby · May 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$14.0M$8.0M$15.0M$9.0M$2.0M
Investing Cash Flow$-20.0M$-24.0M$-11.0M$-2.0M$5.0M
Financing Cash Flow$1.0M$0$0$0$-11.0M
Net Cash Flow$-1.0M$-9.0M$9.0M$7.0M$-2.0M
Free Cash Flow$7.0M$2.0M$10.0M$8.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.02
EV / EBITDA21.79
FCF Yield4.07%
Quick Ratio1.83
Interest Coverage—
Return 1Y-21.83%
Return 3Y-32.15%
Return 5Y-89.44%

Ownership

Insiders Held16.10%
Institutions Held73.65%
Institutions Float Held87.78%
Institutional HolderSharesReport Date
Bandera Partners LLC3,937,2962026-03-31
Skylands Capital, LLC893,1952026-03-31
Blackrock Inc.754,5212026-03-31
Vanguard Capital Management LLC595,6072026-03-31
JCP Investment Management, LLC593,9062026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APYXApyx Medical Corporation $2.37 -1.66% -12.68 $99.83M 0.00%
BTMDBiote Corp. $1.07 -1.83% 6.61 $47.20M 0.00%
CCLDCareCloud, Inc. $1.77 +0.00% 28.94 $75.21M 0.00%
CGTXCognition Therapeutics, Inc. $0.72 +2.60% -4.82 $68.35M 0.00%
DCGODocGo Inc. $0.27 +0.44% -0.19 $26.86M 0.00%

About The Joint Corp.

The Joint Corp. is led by CEO Sanjiv Razdan, employs 443 people, headquartered in US, publicly traded since 2014.

The Joint Corp. (JYNT) stock trades at $7.21 with a market capitalization of $101.90M. The stock is valued at a price-to-earnings (P/E) ratio of 27.44, price-to-book of 6.54, price-to-sales of 1.77. Over the past 52 weeks the stock has ranged between $6.82 and $10.67, and currently trades 32.4% below its 52-week high.

On profitability, The Joint Corp. generates a return on equity (ROE) of 22.00%, above the typical market range of roughly 12-15%, return on capital employed of 5.19%, an operating margin of -1.82%, a net profit margin of 6.49%.

The Joint Corp. by the numbers, 2016–2025

Between 2016 and 2025 The Joint Corp. reported revenue of $21.0M rising to $55.0M, a change of +161.9% across 10 years. Compounded, revenue has grown -1.4% a year over five years, -18.3% over three, 5.8% over the last twelve months. Net profit rose to $3.0M.

Operating margin went from -73.2% in 2016 to -1.6% in 2025, a gain of 71.5 percentage points. The most recent net margin is 6.49%. On a trailing twelve-month basis to Jun '26, revenue is $58.0M and net profit $4.0M.

Borrowings stand at $2.0M, cash from operations was $2.0M in the latest year, positive in 8 of the last 10.

Return on equity has averaged -3.8% over five years, and was 20.0% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

The Joint Corp. (JYNT) — frequently asked questions

What is The Joint Corp. (JYNT) stock price today?

The Joint Corp. (JYNT) is currently trading at $7.21, down 2.24% today.

What is JYNT P/E ratio?

The Joint Corp.'s P/E ratio is 27.44. This is between 15x and 30x, around the typical market average of roughly 18-22x.

What is JYNT return on equity (ROE)?

The Joint Corp.'s return on equity (ROE) is 22.00%. ROE measures net income relative to shareholders' equity. This is above the typical market range of roughly 12-15%.

What is The Joint Corp.'s market cap?

The Joint Corp. has a market capitalization of $101.90M.

Does JYNT pay a dividend?

The Joint Corp. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does JYNT carry?

The Joint Corp. has a debt-to-equity ratio of 0.13. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is JYNT's profit margin?

The Joint Corp. reports a net profit margin of 6.49% — the share of revenue left after every cost, including tax and interest.

What sector is JYNT in?

The Joint Corp. is classified under Healthcare, in the Medical - Care Facilities industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is JYNT listed on?

The Joint Corp. trades on NASDAQ under the ticker JYNT.

What is JYNT's 52-week range?

Over the last year The Joint Corp. has traded between $6.82 and $10.67.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens JYNT currently matches

On the figures above, The Joint Corp. passes the filters for 1 of our ready-made screens, among them Micro Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Micro Cap Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.